Successful Implantation of an EVOQUE-tricuspid Valve Replacement System in a Patient with Two Right Ventricular Implantable Cardioverter-defibrillator Leads: a Case Report

Overview

Journal Eur Heart J Case Rep

Publisher Oxford University Press

Specialty Cardiology & Vascular Diseases

Date 2025 Feb 26

PMID 40008265

Authors

Florian Genske

Christoph Marquetand

Ingo Eitel

Christian Frerker

Tobias Schmidt

Affiliations

Soon will be listed here.

Abstract

Background: Tricuspid regurgitation (TR) is a disease with significant morbidity and mortality rates. Besides surgery and transcatheter edge-to-edge repair (TEER), transcatheter tricuspid valve replacement has evolved as a possible treatment option in high-risk patients with an unfavourable anatomy for TEER.

Case Summary: We present a case of an 82-year-old patient with torrential TR due to an annulus dilation and subsequent central gap of >8 mm. Echocardiographic guiding was impeded by the presence of two permanent right ventricular implantable cardioverter-defibrillator (ICD) leads and previous surgical aortic valve implantation and mitral valve reconstruction. An EVOQUE prosthesis (Edwards Lifesciences; Irvine, USA) was successfully implanted without impairment of the ICD function or significant paravalvular leakage.

Conclusion: Transcatheter tricuspid valve replacement with the EVOQUE-tricuspid valve replacement system is feasible even in patients with two right ventricular ICD leads and limited echocardiographic visibility.

References

Crossley G, Sanders P, De Filippo P, Tarakji K, Hansky B, Shah M . Rationale and design of the Lead Evaluation for Defibrillation and Reliability study: Safety and efficacy of a novel ICD lead design. J Cardiovasc Electrophysiol. 2022; 34(2):257-267. PMC: 10107290. DOI: 10.1111/jce.15747. View

Kodali S, Hahn R, Makkar R, Makar M, Davidson C, Puthumana J . Transfemoral tricuspid valve replacement and one-year outcomes: the TRISCEND study. Eur Heart J. 2023; 44(46):4862-4873. DOI: 10.1093/eurheartj/ehad667. View

Sanchez C, Yakubov S . Simplifying Transcatheter Tricuspid Valve Replacement With 3-Dimensional Intracardiac Echocardiography. J Soc Cardiovasc Angiogr Interv. 2024; 3(4):101347. PMC: 11307963. DOI: 10.1016/j.jscai.2024.101347. View

Zack C, Fender E, Chandrashekar P, Reddy Y, Bennett C, Stulak J . National Trends and Outcomes in Isolated Tricuspid Valve Surgery. J Am Coll Cardiol. 2017; 70(24):2953-2960. DOI: 10.1016/j.jacc.2017.10.039. View

Sorajja P, Whisenant B, Hamid N, Naik H, Makkar R, Tadros P . Transcatheter Repair for Patients with Tricuspid Regurgitation. N Engl J Med. 2023; 388(20):1833-1842. DOI: 10.1056/NEJMoa2300525. View

Taramasso M, Alessandrini H, Latib A, Asami M, Attinger-Toller A, Biasco L . Outcomes After Current Transcatheter Tricuspid Valve Intervention: Mid-Term Results From the International TriValve Registry. JACC Cardiovasc Interv. 2018; 12(2):155-165. DOI: 10.1016/j.jcin.2018.10.022. View

Anderson J, McElhinney D, Aboulhosn J, Zhang Y, Ribichini F, Eicken A . Management and Outcomes of Transvenous Pacing Leads in Patients Undergoing Transcatheter Tricuspid Valve Replacement. JACC Cardiovasc Interv. 2020; 13(17):2012-2020. DOI: 10.1016/j.jcin.2020.04.054. View

Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J . 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2021; 43(7):561-632. DOI: 10.1093/eurheartj/ehab395. View

Fam N, von Bardeleben R, Hensey M, Kodali S, Smith R, Hausleiter J . Transfemoral Transcatheter Tricuspid Valve Replacement With the EVOQUE System: A Multicenter, Observational, First-in-Human Experience. JACC Cardiovasc Interv. 2021; 14(5):501-511. DOI: 10.1016/j.jcin.2020.11.045. View

10.

Axtell A, Bhambhani V, Moonsamy P, Healy E, Picard M, Sundt 3rd T . Surgery Does Not Improve Survival in Patients With Isolated Severe Tricuspid Regurgitation. J Am Coll Cardiol. 2019; 74(6):715-725. PMC: 8890054. DOI: 10.1016/j.jacc.2019.04.028. View

11.

Fam N, Braun D, von Bardeleben R, Nabauer M, Ruf T, Connelly K . Compassionate Use of the PASCAL Transcatheter Valve Repair System for Severe Tricuspid Regurgitation: A Multicenter, Observational, First-in-Human Experience. JACC Cardiovasc Interv. 2019; 12(24):2488-2495. DOI: 10.1016/j.jcin.2019.09.046. View

12.

Lurz J, Rommel K, Unterhuber M, Besler C, Noack T, Borger M . Safety and Efficacy of Transcatheter Edge-to-Edge Repair of the Tricuspid Valve in Patients With Cardiac Implantable Electronic Device Leads. JACC Cardiovasc Interv. 2019; 12(20):2114-2116. DOI: 10.1016/j.jcin.2019.05.034. View

13.

Wang N, Fulcher J, Abeysuriya N, McGrady M, Wilcox I, Celermajer D . Tricuspid regurgitation is associated with increased mortality independent of pulmonary pressures and right heart failure: a systematic review and meta-analysis. Eur Heart J. 2018; 40(5):476-484. DOI: 10.1093/eurheartj/ehy641. View

14.

Webb J, Chuang A, Meier D, von Bardeleben R, Kodali S, Smith R . Transcatheter Tricuspid Valve Replacement With the EVOQUE System: 1-Year Outcomes of a Multicenter, First-in-Human Experience. JACC Cardiovasc Interv. 2022; 15(5):481-491. DOI: 10.1016/j.jcin.2022.01.280. View